Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imidazo[1,5-d][1,2,4]triazines as potential antiasthma agents.

R Paul, J A Brockman, W A Hallett

    Journal of Medicinal Chemistry
    |November 1, 1985
    PubMed
    Summary

    Researchers identified novel imidazo[1,5-d][1,2,4]triazines as potential asthma treatments by inhibiting histamine release from human basophils. Promising compounds demonstrated efficacy in passive cutaneous anaphylaxis tests for further study.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Alterations in central hemodynamic in patients with COPD after acute high intensity exercise.

    Pulmonology·2020
    Same author

    Five-year stroke rate in women with signs and symptoms of ischemia undergoing coronary angiography: a retrospective study from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).

    JRSM open·2015
    Same author

    Sleep disordered breathing and acute mountain sickness in workers rapidly transported to the South Pole (2835 m).

    Respiratory physiology & neurobiology·2015
    Same author

    Determination of blood volume by pulse CO-oximetry.

    Physiological measurement·2011
    Same author

    Variability in pulmonary function following rapid altitude ascent to the Amundsen-Scott South Pole station.

    European journal of applied physiology·2011
    Same author

    Post-menopausal bleeding; its causes and treatment.

    Nursing mirror and midwives journal·2010

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Immunology

    Background:

    • Asthma treatment remains a significant challenge, necessitating the development of novel prophylactic drugs.
    • Histamine release from sensitized human basophils is a key mediator in allergic asthma responses.
    • Identifying compounds that inhibit this release is crucial for developing effective asthma therapies.

    Purpose of the Study:

    • To synthesize and evaluate a series of substituted imidazo[1,5-d][1,2,4]triazines for their potential as prophylactic asthma drugs.
    • To identify compounds that inhibit histamine release from antigen-challenged, sensitized human basophils.
    • To assess the in vivo efficacy of the most active compounds in relevant animal models.

    Main Methods:

    • Synthesis of substituted imidazo[1,5-d][1,2,4]triazines via imidazolecarboxaldehydes, Grignard reagents, oxidation, and pyrolysis.

    Related Experiment Videos

  • Inhibition of histamine release assay using antigen-challenged, sensitized human basophils.
  • In vivo testing using mouse passive cutaneous anaphylaxis (PCA) and guinea pig passive anaphylaxis models.

    • Main Results:

    • A series of substituted imidazo[1,5-d][1,2,4]triazines with significant activity in inhibiting histamine release were identified.
    • Compounds 4-17 (1-ethyl-8-methyl-6-propylimidazo[1,5-d][1,2,4]triazin-4(3H)-one) and 4-16 (1,8-dimethyl-6-propylimidazo[1,5-d][1,2,4]triazin-4-(3H)-one) showed the highest basophil activity.
    • Both compounds demonstrated efficacy in in vivo passive anaphylaxis tests.

    Conclusions:

    • Substituted imidazo[1,5-d][1,2,4]triazines represent a promising class of compounds for asthma prophylaxis.
    • Compounds 4-17 and 4-16 warrant further investigation due to their potent anti-allergic and in vivo activity.
    • The developed synthetic route provides access to novel compounds for asthma therapeutic development.